# PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant

> **NCT01685359** · PHASE1 · COMPLETED · sponsor: **Azidus Brasil** · enrollment: 80 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Epoetin Alfa

## Key facts

- **NCT ID:** NCT01685359
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-28
- **Primary completion:** 2013-10-31
- **Final completion:** 2013-10-31
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01685359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01685359, "PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01685359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*